$Immuneering (IMRX.US)$Immuneering (NASDAQ:IMRX) reported quarterly losses of $(0.49) per share which beat the analyst consensus estimate of $(0.56) by 12.5 percent.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more